2024-515074-26-00招募中1 期
A study to evaluate the safety and tolerability of single ascending doses of AGMB-101 in healthy participants (Part A) and patients with liver cirrhosis (Part B).
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 64
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Operations
Scientific
AgomAb Therapeutics
研究点 (1)
Loading locations...
相似试验
尚未招募
Unknown
Evaluation of a novel test product for treatment of epidermal melasmaCTRI/2023/12/060478SHNI Ventures LLP
已完成
不适用
Safety and tolerability of a vaginal ointment without any active drugs in healthy women.ACTRN12617000778381Zenith Technology Corporation Limited9
招募中
1 期
Investigating the endolift method in the treatment of primary axillary hyperhidrosisIRCT20200127046282N43Tehran University of Medical Sciences10
进行中（未招募）
不适用
Evaluation of efficacy, safety and tolerability of an ADd-on therapy with Cianocabalamine Vitamin B12 plus Calcium levofolinate in relapsing-remitting multiple sclerosis patients Already in treatment with Nterferon beta over a period of 24 months for a better lonterm outComE - ADVANCEMULTIPLE SCLEROSISEUCTR2005-006071-12-ITAZIENDA OSPEDALIERA SAN CAMILLO FORLANINI276
尚未招募
Unknown
Soft capsules with ozonated sunflower oil versus oral OLEOZON® in patients with GiardiosisGiardiosisRPCEC00000440ational Centre for Scientific Research (CNIC)200